US Halts HIV Funding in South Africa Amid Policy Disputes
US to stop funding HIV programmes – The U.S. government has announced plans to cease financial support for HIV initiatives in South Africa. With over eight million individuals affected by the virus, the nation holds the distinction of having the largest HIV population globally. This decision comes amid growing tensions between the two countries, with the U.S. citing South Africa’s alleged shortcomings in protecting its white-minority Afrikaner community as a key factor.
Political Context and Funding Shift
Relations between the U.S. and South Africa have deteriorated since Trump’s presidency began. Shortly after assuming office, Trump issued an executive order accusing South Africa of policies that allegedly undermined equal opportunities and targeted racially disadvantaged landowners. The order also highlighted the country’s case against Israel at the International Court of Justice and its diplomatic ties with Iran. The White House argued that these “unjust and immoral practices” justified withholding further aid.
“Countless South African policies have dismantled equal opportunities and fueled violence against racially disfavored landowners,” claimed the executive order.
The South African government has consistently rejected these claims, emphasizing that its Black Economic Empowerment (BEE) policy is essential for addressing economic inequalities stemming from the apartheid era. According to officials, BEE programs have successfully promoted diversity in employment, business ownership, and government contracts. Despite this, the U.S. has maintained its stance, linking the funding cut to perceived racial bias in South African governance.
The Role of Pepfar and South Africa’s Self-Reliance Strategy
Until 2025, the U.S. had been providing annual support of approximately $400 million via the President’s Emergency Fund for AIDS Relief (PEPFAR) to combat the virus. South Africa’s health ministry, however, stated that although it was not informed of the decision, it had already been developing a self-sufficiency strategy to reduce reliance on external aid. The ministry noted that life-saving antiretroviral drugs are primarily funded through the government’s own resources, independent of PEPFAR.
PEPFAR funding, which accounted for roughly 20% of South Africa’s HIV program expenditures, received a temporary extension in October through a “bridge plan.” Yet, a U.S. State Department official confirmed the start of a “phased drawdown” in the funding. This move was justified by the official as a response to South Africa’s “failure to make demonstrable progress on policy requests by the administration,” aiming to “foster self-reliance” and decrease dependence on American support.
Refugee Program and Racial Allegations
Trump’s administration has also launched a refugee program specifically for Afrikaners, descendants of Western Europeans who settled in southern Africa during the 17th century. This initiative, framed as a response to the “white genocide” narrative, has made Afrikaners the primary group being accepted as refugees into the U.S. The claim of a “white genocide” has been widely discredited, yet it remains a central argument in the U.S. government’s decision to redirect aid.
“Trump has falsely alleged that a ‘white genocide’ is taking place in South Africa,” stated the South African government.
Despite the government’s refutations, the refugee program underscores the growing emphasis on racial issues in U.S.-South Africa relations. Critics argue that the move reflects a broader strategy to criticize South Africa’s social policies while advancing a narrative of racial persecution. This has sparked debates about whether the U.S. is using the HIV funding cut as a tool to highlight perceived injustices in the country’s governance.
Impact on Global Health and Bilateral Ties
The decision to halt PEPFAR funding raises concerns about the effectiveness of
